BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 25994754)

  • 21. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.
    Chu SY; Jiang J; Wang YL; Sheng QH; Zhou J; Ding YS
    Heart Lung; 2020; 49(1):66-72. PubMed ID: 31376922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of patients with valvular and non-valvular atrial fibrillation in Poland: Results from Reference Cardiology University Center.
    Łopatowska P; Tomaszuk-Kazberuk A; Młodawska E; Bachórzewska-Gajewska H; Małyszko J; Dobrzycki S; Musiał WJ
    Cardiol J; 2015; 22(3):296-305. PubMed ID: 25428729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation. The Loire Valley Atrial Fibrillation Project.
    Banerjee A; Fauchier L; Bernard-Brunet A; Clementy N; Lip GY
    Thromb Haemost; 2014 Mar; 111(3):549-56. PubMed ID: 24452108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
    Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
    Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
    Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
    Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation.
    Ntaios G; Lip GY; Lambrou D; Papavasileiou V; Manios E; Milionis H; Spengos K; Makaritsis K; Vemmos K
    Neurology; 2015 Mar; 84(12):1213-9. PubMed ID: 25695964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
    Avezum A; Lopes RD; Schulte PJ; Lanas F; Gersh BJ; Hanna M; Pais P; Erol C; Diaz R; Bahit MC; Bartunek J; De Caterina R; Goto S; Ruzyllo W; Zhu J; Granger CB; Alexander JH
    Circulation; 2015 Aug; 132(8):624-32. PubMed ID: 26106009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry.
    Tezuka Y; Iguchi M; Hamatani Y; Ogawa H; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
    Eur Heart J Qual Care Clin Outcomes; 2020 Oct; 6(4):273-283. PubMed ID: 31977011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.
    Lip GY; Frison L; Halperin JL; Lane DA
    Stroke; 2010 Dec; 41(12):2731-8. PubMed ID: 20966417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA
    Bel-Ange A; Itskovich SZ; Avivi L; Stav K; Efrati S; Beberashvili I
    BMC Nephrol; 2021 May; 22(1):179. PubMed ID: 33992086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the Cox-maze procedure for atrial fibrillation concomitant to mitral and tricuspid valve surgery.
    Ad N; Holmes SD; Massimiano PS; Pritchard G; Stone LE; Henry L
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1426-34; discussion 1434-5. PubMed ID: 24075462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carotid plaque detection improves the predictive value of CHA
    Basili S; Loffredo L; Pastori D; Proietti M; Farcomeni A; Vestri AR; Pignatelli P; Davì G; Hiatt WR; Lip GY; Corazza GR; Perticone F; Violi F;
    Int J Cardiol; 2017 Mar; 231():143-149. PubMed ID: 28087176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
    Stortecky S; Buellesfeld L; Wenaweser P; Heg D; Pilgrim T; Khattab AA; Gloekler S; Huber C; Nietlispach F; Meier B; Jüni P; Windecker S
    Circ Cardiovasc Interv; 2013 Feb; 6(1):77-84. PubMed ID: 23386662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
    Saliba W; Rennert G
    Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.